IRF1 and cholangiocarcinoma: In the miR-383/IRF1 pathway, IRF1 is a functional miR-383 target, so a negative correlation was found between the expression levels of IRF1 and miR-383 in cholangiocarcinoma tissues (Wan et al., 2018a).